DDW update by Dr. Maheshwari 2016

                i.         EUS based Hepatic vein portal gradient – first humanized trial done with success.  Use – for example Renal transplant patient with cirrhosis. Poor outcome if gradient more than 12

              ii.         Doppler Endoscopic probe :  Used to assess efficacy of variceal bleed banding

             iii.         C diff : Overall cure rate with FMT is 82%, cure rate for recurrent CDI with colonoscopy was 87% compared to UGI instillation was 69%.  Data from Openbiome, Meford Ma

             iv.         Recurrent CDI was not higher if patients were on PPI / acid suppression

              v.         Metaanalysis showed robust efficacy of prevention of CDI with use of probiotics.   Strains and dose not yet clear.